VEPH1 suppresses the progression of gastric cancer by regulating the Hippo-YAP signalling pathway

Dig Liver Dis. 2024 Jan;56(1):187-197. doi: 10.1016/j.dld.2023.05.014. Epub 2023 May 25.

Abstract

Background: Ventricular zone-expressed PH domain-containing protein homologue 1 (VEPH1) is a recently discovered intracellular adaptor protein that plays an important role in human development. It has been reported that VEPH1 is closely related to the process of cellular malignancy, but its role in gastric cancer has not been elucidated. This study investigated the expression and function of VEPH1 in human gastric cancer (GC).

Methods: We performed qRT‒PCR, Western blotting, and immunostaining assays in GC tissue samples to evaluate VEPH1 expression. Functional experiments were used to measure the malignancy of GC cells. A subcutaneous tumorigenesis model and peritoneal graft tumour model were established in BALB/c mice to determine tumour growth and metastasis in vivo.

Results: VEPH1 expression is decreased in GC and correlates with the overall survival rates of GC patients. VEPH1 inhibits GC cell proliferation, migration, and invasion in vitro and suppresses tumour growth and metastasis in vivo. VEPH1 regulates the function of GC cells by inhibiting the Hippo-YAP signalling pathway, and YAP/TAZ inhibitor-1 treatment reverses the VEPH1 knockdown-mediated increase in the proliferation, migration and invasion of GC cells in vitro. Loss of VEPH1 is associated with increased YAP activity and accelerated epithelial-mesenchymal transition (EMT) in GC.

Conclusion: VEPH1 inhibited GC cell proliferation, migration, and invasion in vitro and in vivo and exerted its antitumour effects by inhibiting the Hippo-YAP signalling pathway and EMT process in GC.

Keywords: Epithelial-mesenchymal transition; Gastric cancer; Hippo pathway; VEPH1; Yes-Associated Protein.

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Animals
  • Cell Line, Tumor
  • Cell Proliferation
  • Humans
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Intracellular Signaling Peptides and Proteins / pharmacology
  • Mice
  • Signal Transduction*
  • Stomach Neoplasms* / pathology

Substances

  • Adaptor Proteins, Signal Transducing
  • VEPH1 protein, human
  • Intracellular Signaling Peptides and Proteins